DE69109581D1 - Bioerodierbare Implantate. - Google Patents

Bioerodierbare Implantate.

Info

Publication number
DE69109581D1
DE69109581D1 DE69109581T DE69109581T DE69109581D1 DE 69109581 D1 DE69109581 D1 DE 69109581D1 DE 69109581 T DE69109581 T DE 69109581T DE 69109581 T DE69109581 T DE 69109581T DE 69109581 D1 DE69109581 D1 DE 69109581D1
Authority
DE
Germany
Prior art keywords
beneficial agents
bioerodible implants
beneficial
bioerodible
condensing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69109581T
Other languages
English (en)
Other versions
DE69109581T2 (de
Inventor
Chung Shih
Randall V Sparer
Gaylen M Zentner
Randolph Lee Seward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69109581D1 publication Critical patent/DE69109581D1/de
Application granted granted Critical
Publication of DE69109581T2 publication Critical patent/DE69109581T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Biological Depolymerization Polymers (AREA)
DE69109581T 1990-08-22 1991-08-15 Bioerodierbare Implantate. Expired - Fee Related DE69109581T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57074290A 1990-08-22 1990-08-22

Publications (2)

Publication Number Publication Date
DE69109581D1 true DE69109581D1 (de) 1995-06-14
DE69109581T2 DE69109581T2 (de) 1996-01-18

Family

ID=24280874

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69109581T Expired - Fee Related DE69109581T2 (de) 1990-08-22 1991-08-15 Bioerodierbare Implantate.

Country Status (13)

Country Link
US (1) US5837228A (de)
EP (1) EP0473223B1 (de)
JP (1) JP2588328B2 (de)
AT (1) ATE122230T1 (de)
AU (1) AU645594B2 (de)
CA (1) CA2049668C (de)
DE (1) DE69109581T2 (de)
DK (1) DK0473223T3 (de)
ES (1) ES2072530T3 (de)
IE (1) IE67141B1 (de)
IL (1) IL99180A (de)
NZ (1) NZ239370A (de)
PT (1) PT98708B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211951A (en) * 1991-07-24 1993-05-18 Merck & Co., Inc. Process for the manufacture of bioerodible poly (orthoester)s and polyacetals
KR100374098B1 (ko) * 1994-04-08 2003-06-09 아트릭스 라보라토리스, 인코포레이션 조절된방출이식편형성에적합한액체전달조성물
EP1014970A1 (de) * 1997-09-23 2000-07-05 Pfizer Limited Schädlingsbekämpfungsmittel
US6524602B1 (en) * 1998-10-13 2003-02-25 Craig G. Burkhart Polymer delivery system in treatments for parasitic skin diseases
CZ20013269A3 (cs) * 1999-03-11 2002-04-17 Société des Produits Nestlé S. A. Bakterie mléčného kvaąení
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US20050042194A1 (en) 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
AU2001288829A1 (en) 2000-09-06 2002-03-22 Ap Pharma, Inc. Degradable polyacetal polymers
CA2429898C (en) * 2000-11-16 2011-02-22 Durect Corporation Devices and methods for cholesterol management
US6590059B2 (en) 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US20050009762A1 (en) 2003-06-06 2005-01-13 Strobel Michael Albert Application of water and organic solvent soluble ivermectin for topical and oral use
US6627613B2 (en) 2001-07-23 2003-09-30 Michael A. Strobel Application of water and organic solvent soluble ivermectin for topical and oral use
US20040142902A1 (en) * 2001-11-08 2004-07-22 Struijker- Boudier Harry A.J. Implant dosage form and use thereof for the delivery of a cholosterol lowering agent
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US7288609B1 (en) * 2003-03-04 2007-10-30 Advanced Cardiovascular Systems, Inc. Coatings for drug delivery devices based on poly (orthoesters)
CA2525631C (en) * 2003-05-13 2012-12-18 Medtronic, Inc. Moisture curable materials for delivery of agents, methods, and medical devices
CA2575988C (en) 2004-08-04 2014-02-18 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US20070265329A1 (en) * 2006-05-12 2007-11-15 Devang Shah T Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
US20070264338A1 (en) * 2006-05-12 2007-11-15 Shah Devang T Base-stabilized polyorthoester formulations
US20070264339A1 (en) * 2006-05-12 2007-11-15 Ap Pharma, Inc. Base-stabilized polyorthoester formulations
EP2044142A2 (de) 2006-06-29 2009-04-08 Medtronic, Inc. Poly(orthoester)polymere sowie herstellungs- und verwendungsverfahren dafür
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
US8940315B2 (en) 2008-04-18 2015-01-27 Medtronic, Inc. Benzodiazepine formulation in a polyorthoester carrier
US8956642B2 (en) 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
US20100152227A1 (en) * 2008-12-11 2010-06-17 A.P. Pharma, Inc. Methods for Enhancing Stability of Polyorthoesters and Their Formulations
CN103153313A (zh) 2010-07-30 2013-06-12 法国诗华动物保健公司 用于防治恶丝虫侵袭的组合物
EP3682887A1 (de) * 2010-07-30 2020-07-22 Ceva Sante Animale Zusammensetzungen enthaltend ivermectin zur bekämpfung von herzwurmbefall
CA2857958C (en) 2011-12-02 2020-08-25 Merial Limited Long-acting injectable moxidectin formulations and moxidectin crystal forms
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4150108A (en) * 1975-12-29 1979-04-17 Graham Neil B Injectable medicinal compositions
JPS5441319A (en) * 1977-06-28 1979-04-02 Uni Sutorasukuraido Za Pharmaceutical composition for treating tropic desease
US4356166A (en) * 1978-12-08 1982-10-26 University Of Utah Time-release chemical delivery system
US4304767A (en) * 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US4636387A (en) * 1982-06-21 1987-01-13 Research Corporation Anesthetic polyorganophosphazenes
US4639366A (en) * 1984-06-06 1987-01-27 Merck & Co., Inc. Polymers containing pendant acid functionalities and labile backbone bonds
US4765973A (en) * 1984-06-06 1988-08-23 Merck & Co., Inc. Polymers containing pendant acid functionalities and labile backbone bonds
US4764764A (en) * 1984-11-27 1988-08-16 Honeywell Inc. Write-protect apparatus for bit mapped memory
CS254355B1 (en) * 1985-04-10 1988-01-15 Vladimir Saudek Soluble and biodegradatable copolymeres activated for bond of biologicaly active substances
US4764364A (en) * 1986-02-25 1988-08-16 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
AU2902289A (en) * 1987-12-08 1989-07-05 Mark Chasin Method of forming bioerodible implants for improved controlled drug release

Also Published As

Publication number Publication date
CA2049668A1 (en) 1992-02-23
IL99180A (en) 1998-01-04
AU645594B2 (en) 1994-01-20
EP0473223B1 (de) 1995-05-10
PT98708B (pt) 1999-01-29
PT98708A (pt) 1992-08-31
US5837228A (en) 1998-11-17
JP2588328B2 (ja) 1997-03-05
EP0473223A1 (de) 1992-03-04
JPH04230621A (ja) 1992-08-19
NZ239370A (en) 1994-04-27
DK0473223T3 (da) 1995-07-10
IE67141B1 (en) 1996-03-06
ES2072530T3 (es) 1995-07-16
AU8267891A (en) 1992-02-27
IL99180A0 (en) 1992-07-15
DE69109581T2 (de) 1996-01-18
ATE122230T1 (de) 1995-05-15
CA2049668C (en) 2002-11-12
IE912965A1 (en) 1992-02-26

Similar Documents

Publication Publication Date Title
DE69109581D1 (de) Bioerodierbare Implantate.
GR880100555A (en) Hydrophilous polymers for deodorants incorporation in absorbing constructions
BR9711829A (pt) Implante cirúrgico contendo um marcador radiopaco ressorvìvel.
DE69516960T2 (de) Sulfatierte hyaluronsäure mit 0.5 bis weniger als 2 sulfate gruppen pro einheit
ES2075249T3 (es) Dispositivo adhesivo para la administracion transdermica de un agente activo.
ITFI910071U1 (it) Piastra per osso per la porzione distale dell'omero.
DE58906467D1 (de) Formkörper aus verformbarem Knochenersatzmaterial.
CA2041774A1 (en) Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
SE9102778D0 (sv) Implanterbar medicinsk anordning
ES2049381T3 (es) Cuerpos absorbentes.
MY106910A (en) Absorbent article
DK108788A (da) Vaeskeabsorberende artikel til engangsanvendelse
SE8205603L (sv) Kateter med delvis forstyvad del
ES2077757T3 (es) Preparacion farmaceutica solida con disolucion rapida que contiene la s-(carboximetil)-l-cisteina y/o la n-acetilcisteina.
PT673649E (pt) Composicoes farmaceuticas que permitem a libertacao prolongada de trimetazidina apos administracao por via oral
ATE123215T1 (de) Künstliche hornhaut.
ES2100354T3 (es) Sistema de implante nervioso.
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
IT1231509B (it) Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
MX173529B (es) Composicion adhesiva antibacteriana
FR2681777B1 (fr) Clou chirurgical implantable dans l'os.
ES2103220B1 (es) Desodorantes de los efluentes de papelera a base de ester de acido undecilenico.
DK0468351T3 (da) Ortopædisk terapisko og indersko
SE8107352L (sv) Kondranol for transplantat
RU92005670A (ru) Полимерная композиция для получения хирургического цемента

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee